CPAP versus oxygen in obstructive sleep apnea.

BACKGROUND Obstructive sleep apnea is associated with hypertension, inflammation, and increased cardiovascular risk. Continuous positive airway pressure (CPAP) reduces blood pressure, but adherence is often suboptimal, and the benefit beyond management of conventional risk factors is uncertain. Since intermittent hypoxemia may underlie cardiovascular sequelae of sleep apnea, we evaluated the effects of nocturnal supplemental oxygen and CPAP on markers of cardiovascular risk. METHODS We conducted a randomized, controlled trial in which patients with cardiovascular disease or multiple cardiovascular risk factors were recruited from cardiology practices. Patients were screened for obstructive sleep apnea with the use of the Berlin questionnaire, and home sleep testing was used to establish the diagnosis. Participants with an apnea-hypopnea index of 15 to 50 events per hour were randomly assigned to receive education on sleep hygiene and healthy lifestyle alone (the control group) or, in addition to education, either CPAP or nocturnal supplemental oxygen. Cardiovascular risk was assessed at baseline and after 12 weeks of the study treatment. The primary outcome was 24-hour mean arterial pressure. RESULTS Of 318 patients who underwent randomization, 281 (88%) could be evaluated for ambulatory blood pressure at both baseline and follow-up. On average, the 24-hour mean arterial pressure at 12 weeks was lower in the group receiving CPAP than in the control group (-2.4 mm Hg; 95% confidence interval [CI], -4.7 to -0.1; P=0.04) or the group receiving supplemental oxygen (-2.8 mm Hg; 95% CI, -5.1 to -0.5; P=0.02). There was no significant difference in the 24-hour mean arterial pressure between the control group and the group receiving oxygen. A sensitivity analysis performed with the use of multiple imputation approaches to assess the effect of missing data did not change the results of the primary analysis. CONCLUSIONS In patients with cardiovascular disease or multiple cardiovascular risk factors, the treatment of obstructive sleep apnea with CPAP, but not nocturnal supplemental oxygen, resulted in a significant reduction in blood pressure. (Funded by the National Heart, Lung, and Blood Institute and others; HeartBEAT ClinicalTrials.gov number, NCT01086800 .).

[1]  Ferran Barbé,et al.  Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of Hypertension , 2013 .

[2]  J. Montserrat,et al.  Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. , 2012, JAMA.

[3]  Ferran Barbé,et al.  Association between treated and untreated obstructive sleep apnea and risk of hypertension. , 2012, JAMA.

[4]  N. Punjabi.  Do Sleep Disorders and Associated Treatments Impact Glucose Metabolism? , 2012, Drugs.

[5]  J. Montserrat,et al.  Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial , 2010, BMJ : British Medical Journal.

[6]  J. Pépin,et al.  Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. , 2010, American journal of respiratory and critical care medicine.

[7]  P. Lloberes,et al.  Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial , 2010, Journal of hypertension.

[8]  A. Newman,et al.  Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure: The Sleep Heart Health Study , 2010, Circulation.

[9]  J. Taylor,et al.  14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans , 2010, European Respiratory Journal.

[10]  J. Montserrat,et al.  Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. , 2010, American journal of respiratory and critical care medicine.

[11]  Cathy Goldstein,et al.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. , 2010, American journal of respiratory and critical care medicine.

[12]  A. Logan,et al.  Can nocturnal hypertension predict cardiovascular risk? , 2009, Integrated blood pressure control.

[13]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[14]  M. Law.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009 .

[15]  S. Jelić,et al.  Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. , 2008, Trends in cardiovascular medicine.

[16]  J. Stradling,et al.  Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial , 2008, Thorax.

[17]  T. Young,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[18]  W. Elliott.  Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea , 2008 .

[19]  W. McNicholas,et al.  Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. , 2008, Archives of physiology and biochemistry.

[20]  K. Reynolds,et al.  Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea , 2007, Hypertension.

[21]  A. Chesson,et al.  The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications , 2007 .

[22]  A. Chesson,et al.  The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Techinical Specifications , 2007 .

[23]  H. Greenberg,et al.  Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. , 2006, Biochemical and biophysical research communications.

[24]  S. Ancoli-Israel,et al.  Effects of Continuous Positive Airway Pressure Versus Supplemental Oxygen on 24-Hour Ambulatory Blood Pressure , 2006, Hypertension.

[25]  S. Ancoli-Israel,et al.  Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. , 2006, Sleep.

[26]  J. Concato,et al.  Obstructive sleep apnea as a risk factor for stroke and death. , 2005, The New England journal of medicine.

[27]  W. McNicholas,et al.  Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. , 2005, Chest.

[28]  D. Gottlieb,et al.  Sleepiness in patients with moderate to severe sleep-disordered breathing. , 2005, Sleep.

[29]  Jose M Marin,et al.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study , 2005, The Lancet.

[30]  G. Jondeau,et al.  Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. , 2004, European heart journal.

[31]  Adelaide M. Arruda-Olson,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[32]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[33]  Jan Hedner,et al.  Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. , 2002, American journal of respiratory and critical care medicine.

[34]  Sc Prospective,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002 .

[35]  T. Rabben,et al.  Sleep-disordered breathing and coronary artery disease: long-term prognosis. , 2001, American journal of respiratory and critical care medicine.

[36]  V. Yohai,et al.  Robust regression with both continuous and categorical predictors , 2000 .

[37]  T. Young,et al.  Prospective study of the association between sleep-disordered breathing and hypertension. , 2000, The New England journal of medicine.

[38]  Bonnie K. Lind,et al.  Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study , 2000 .

[39]  P. L. Smith,et al.  Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea. , 2000, Journal of applied physiology.

[40]  K. Strohl,et al.  Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome , 1999, Annals of Internal Medicine.

[41]  N. Douglas,et al.  Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. , 1999, American journal of respiratory and critical care medicine.

[42]  E. Phillipson,et al.  Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. , 1997, The Journal of clinical investigation.

[43]  T. Young,et al.  The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.

[44]  E. Fletcher,et al.  Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. , 1992, Hypertension.

[45]  D T Berry,et al.  Treatment of obstructive sleep apnea : a preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA , 1990 .

[46]  F. Abboud,et al.  Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. , 1989, Journal of applied physiology.